CD44 expression predicts local recurrence after radiotherapy in larynx cancer

Authors: Monique C. de Jong, Jimmy Pramana, Jacqueline E. van der Wal, Martin Lacko, Carine J. Peutz-Kootstra, Jos M.A. de Jong, Robert P. Takes, Johannes H. Kaanders, Bernard van der Laan, Jasper Wachters, Jeroen C. Jansen, Coen R.N. Rasch, Marie-Louise F. van Velthuysen, Reidar Grénman, Frank J. Hoebers, Ed M.D. Schuuring, Michiel W.M. van den Brekel, Adrian C. Begg

This article was published in Clinical Cancer Research, Volume number 16(21), Pages 5329-38, Copyright American Association for Cancer Research (2010), reprinted with permission.

View article in Pubmed

Read commentary  ‘CD44: A cancer stem cell-related biomarker with predictive potential for radiotherapy’ by Michael Baumann and Mechthild Krause in the same issue of Clinical Cancer Research.